Ryan Kerstein

VivoMedica Plc engages in identifying and exploiting product development opportunities in the medical technology sector. The company was founded September 6, 2000 and is headquartered in Bury, the United Kingdom.

Evonik Advanced Botanicals SAS operates as biopharmaceutical company. It focuses on the identification, validation, manufacture, and commercialization of cancer treatments for the management of multidrug resistant (MDR) cancers. The company was founded by Franck Michoux in 2011 and is headquartered in Evry, France.

Upperton Ltd. is a British pharmaceutical company that offers a range of services to support product development, including identification, development, monitoring, and quality control testing. Upperton is based in Nottingham, UK, and was founded in 1999 by Richard Johnson. The company has an experienced analytical team that works in conjunction with formulators to ensure the success of all projects. The company offers flexible and dynamic GMP manufacturing services for clinical supplies, from first in human through to phase III clinical supplies manufacturing. The company has extensive experience taking research projects from early proof of concept and feasibility through scale-up and onto clinical manufacture for a range of common dosage forms. The CEO is Nikki Whitfield.

Duke Street LLP (Duke Street) is a private equity firm founded in 1988 by Edmund Turell. The firm is headquartered in London, the United Kingdom.

Inflexion Private Equity Partners LLP (Inflexion Private Equity Partners) is a private equity firm founded in 1999 by John Frederick Hartz and Simon Eric Hugh Turner. The firm is headquartered in London, United Kingdom.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

AlveoGene Ltd. is a British dormant company that was founded in 2022. The company is based in Oxford, UK.

Charco Neurotech Ltd. is a British company that aims to improve the quality of life for people with Parkinson's disease. The company is based in London, UK and was founded in 2014 by Floyd Pierres and Soo-Min Jung, who has been the CEO since then. The company has developed a non-invasive wearable device called CUE1, which offers a novel approach to managing the symptoms of Parkinson's.

NeuroproteXeon Ltd. engages in developing of xenon gas for inhalation for the treatment of Post-Cardiac Arrest Syndrome. The company was founded on September 3, 2014 and is headquartered in Abingdon, the United Kingdom.

PBB Devices Ltd. is engaged in the commercialization of scientific research into optoelectronics and the provision of legal manufacturer services. The firm offers products for various applications, such as general practitioner and physician offices and routine assessment of diabetic complications. The company was founded by Jody Brown, Vincent Peter Crabtree and Peter Smith on September 25, 2002 and is headquartered in Reading, the United Kingdom.

Novellus Systems, Inc. manufactures and services advanced automated wafer fabrication systems. The company was founded by Brad Mattson on April 11, 1984 and is headquartered in Fremont, CA.

ESP Technology Ltd. develops materials and technologies for the treatment and care of kidney failure patients. It develops a unique material and processing technology that can be used by developers of vascular access grafts to enhance their products as well as reducing patient treatment time. The company was founded by Chirs Underwood in 2011 and is headquartered in Daresbury, the United Kingdom.

CardioTech International LLC is a private company that manufactures blood pressure monitors. The company is based in Rockville, MD and has subsidiaries in the United States.

Part of LeMaitre Vascular, Inc., Credent Vascular Technologies Ltd is a British company that manufactures vascular surgery devices. The company is based in Wrexham, UK. Credent Vascular Technologies was acquired by LeMaitre Vascular, Inc. on April 29, 2003.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.